Lisdexamfetamine 50 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FRCVN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,007
Award facts
- Contract value 100% obligated
- $1,006.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100 units, with a ceiling value of $1,006.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order for Lisdexamfetamine, a medication used in the treatment of attention deficit hyperactivity disorder, represents a routine transaction within AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FRCVN?
SPE2DB25FRCVN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FRCVN worth?
The government has obligated $1,007 on SPE2DB25FRCVN.
Is contract SPE2DB25FRCVN an order under another contract?
Yes. SPE2DB25FRCVN is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCVN competed?
The extent of competition for SPE2DB25FRCVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award